Ingredient guide · Ingredient reference

Quercetin phytosome and pollen symptoms: a product-specific trial

A four-week trial reported improvements in selected allergy questionnaire scores. It did not compare the supplement with an antihistamine.

Read the evidence ↓

Supplement Science Insights Editorial Team

Published September 23, 2026

The study and its comparison

Sixty-six Japanese adults with pollinosis symptoms were randomized to a formulation providing 200 mg quercetin daily or a vehicle control for four weeks. The product used a phytosome formulation. [1]

Several reported eye, nose, sleep and quality-of-life scores favored the supplement during follow-up. The study concerns those symptom measures and that preparation. [1]

What the finding establishes

It does not establish equal effectiveness to prescribed allergy treatments or a universal effect of every quercetin powder. Short duration and questionnaire outcomes limit interpretation. Funding and conflicts were not established from the abstract; allergy care should not be replaced on this basis. [1]

A hypothetical distinction

Imagine a formulated product beats its vehicle. That does not rank it against an antihistamine that was never tested.

Interpretation checklist — Quercetin phytosome and pollen symptoms
DetailInterpretation
Measured outcomeKeep the endpoint specific
Study preparationNot every retail product
Remaining uncertaintyNot resolved by a mechanism
Quercetin phytosome and pollen symptoms: a product-specific trial — original article outline diagram
Original editorial diagram of this article’s sections; no product photograph or clinical finding is depicted.

Sources for this article

  1. Effects of repeated oral intake of a quercetin-containing supplement on allergic reaction: a randomized, placebo-controlled, double-blind parallel-group study.
    Source consulted: 2026-09-19. This is a reference resource, not a claim that we conducted the studies or tested a product.